INSIGHTS ON QUALITY ASSURANCE
-
High Precision Mass Inspection With Accuracy Of ±0.5 mg Achieved
Explore how advances in capsule checkweighing technology enable more precise mass inspection, helping improve quality control, reduce variability, and meet increasingly stringent production requirements.
-
Development Of COVID-19 Vaccine Production During A Pandemic
See how seamless teamwork and automated electrophoresis systems ensured rapid, reliable COVID-19 vaccine production support and how their collaboration made a difference.
-
Pharmaceutical X-Ray Counts Capsules & Pills
Learn how advanced X-ray inspection ensures exact pill counts in multi-supplement pouches, automatically identifying missing components and generating time-stamped visual data logs.
-
Inside The Cleanroom: Building A Culture Of Clean Beyond The CCS Blueprint
Achieving sterile excellence requires more than just rigid protocols. Learn how to foster a proactive mindset across your entire organization to ensure long-term facility integrity.
-
Denaturing SEC-MS Analysis Of High Molecular Weight Impurities3/18/2026
Look at how denaturing SEC‑MS uncovers low‑level oligomers and truncated variants in GLP‑1 peptides, offering clarity on impurity profiles and supporting confident assessment of molecular integrity.
-
FDA's CSA Guidance Is Final: What It Means For Your Validation Strategy3/23/2026
Understand the FDA's shift from rigid CSV to risk-based software assurance. Binary risk classification and flexible testing approaches reduce validation timelines for production and quality.
-
Choosing The Best mRNA Manufacturing Strategy12/12/2025
Choosing the right mRNA manufacturing model can define your success. Learn how to weigh control, cost, and flexibility to build a strategy that supports innovation and long-term growth.
-
Closed Sampling: Crucial For Aseptic Processing6/26/2025
Explore the critical role of closed sampling in bioprocessing by gaining insight into regulatory frameworks, system integrity, and aseptic practices essential to ensure compliance and product quality.
-
EU And PIC/S Annex 1: CCS Shortfalls After 2 Years Of Implementation4/16/2026
Explore how to elevate Contamination Control Strategies from static documents to inspection-ready, lifecycle tools, as well as practical approaches to Annex 1 compliance and risk-based CCS development.
QUALITY ASSURANCE SOLUTIONS
-
Automate research and clinical workflows with intuitive setup, fewer errors, and optimized instrument use that supports regulated environments and delivers personalized service.
-
Take a look at scalable packaging capabilities spanning primary, secondary, and serialization processes that are designed to improve accuracy, support compliance, and accelerate timelines.
-
Act with certainty during contamination events. Learn a proven four-step process to identify root causes, restore environmental control, and implement effective CAPAs to prevent recurrence.
-
Accelerate your gene therapy manufacturing with the Xcellerex™ X-platform – a next-generation single-use bioreactor system designed for viral vector workflows.
-
Ensure sterile integrity and personnel safety during hazardous drug handling. Optimize workflows with advanced containment technology that adapts to complex facility and processing requirements.